Why shouldn’t newborns with jaundice be exposed to blue light at 14 o’clock?

Why should neonatal jaundice 14mg/dl not be illuminated with blue light? There is no such saying. Whether neonatal jaundice 14mg/dl needs to be illuminated with blue light depends mainly on the cause of jaundice.

Neonatal jaundice, also known as neonatal hyperbilirubinemia, is a common physiological disease in newborns. It is caused by abnormal bilirubin metabolism in the blood, which leads to elevated bilirubin. It cannot be excreted from the body in time, resulting in yellow staining of organs such as the skin and mucous membranes. In clinical practice, if the bilirubin is greater than 12.9 mg/dl or the bilirubin in the venous blood reaches 220, hospitalization for blue light therapy is recommended. When the neonatal jaundice is 14 mg/dl, oral probiotics can be taken to regulate the intestines, promote defecation, and excrete bilirubin with feces to reduce jaundice. Blue light therapy can also be performed to treat jaundice.

Blue light therapy should be performed under strict medical conditions and should not be used blindly. Excessive or incorrect use of blue light therapy devices can damage the skin and eyes of newborns and may cause keratitis, blindness and other problems. Most newborns with physiological jaundice can quickly return to normal after one or two days of blue light therapy.